Physician profile
John A Nicholson
NPI 1801823745
$745.24
in general payments reported to CMS, 2019-2025
17 companies · $134 in 2025
The $134 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $141 · 2021: $105 · 2022: $150 · 2023: $70.04 · 2024: $19.38 · 2025: $134.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $223.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $119.67 | 2025 | Senza |
| Lundbeck LLC | $107.63 | 2022 | |
| Arbor Pharmaceuticals, INC. | $106.07 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $65.93 | 2020-2021 | |
| Assertio Therapeutics, INC. | $53.81 | 2019 | |
| Electronic Waveform Lab, INC. | $50.88 | 2023-2024 | |
| Si-Bone, INC. | $45.85 | 2020-2021 | |
| Abbott Laboratories | $29.89 | 2019-2022 | |
| Lilly USA, LLC | $26.01 | 2022-2025 | Jardiance |
| Nevro Corp. | $25.74 | 2023 | Senza |
| Sonex Health, INC. | $20.71 | 2020 | |
| Almatica Pharma LLC | $19.78 | 2021 | |
| Pfizer INC. | $15.90 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $15.40 | 2022 | |
| Avanos Medical | $14.84 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Surgalign Spine Technologies, INC. | $14.33 | 2019 | |
| Amgen INC. | $12.80 | 2023 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Nicholson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.